Wednesday , March 4 2026
Home / Media OutReach (page 709)

Media OutReach

Berlin Cures’ BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial

Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients in randomized placebo-controlled Phase-II-trial now recruited; no issues regarding safety observed. Berlin Cures innovative platform develops novel aptamer-based drugs to neutralize pathogenic functional autoantibodies, targeting …

Read More »

Heng An Standard Life (Asia) fully supports Hong Kong new Capital Investment Entrant Scheme with ILAS now available for application

HONG KONG SAR – Media OutReach Newswire – 4 March 2024 – Heng An Standard Life (Asia) Limited (“HASL Asia” or “the Company”) welcomes and fully supports Hong Kong new Capital Investment Entrant Scheme (CIES). The company is committed to tying in with government policies to improve Hong Kong’s competitive …

Read More »

Berlin Cures’ BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment

Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients in randomized placebo-controlled Phase-II-trial now recruited; no issues regarding safety observed. Berlin Cures innovative platform develops novel aptamer-based drugs to neutralize pathogenic functional autoantibodies, targeting …

Read More »

Kaohsiung Draws Potential Investors at Kumamoto Expo

KAOHSIUNG, TAIWAN – Media OutReach Newswire – 4 March 2024 – Headed by Deputy Mayor Lo Ta-sheng, the Kaohsiung delegation to KUMAMOTO Industrial Revitalization EXPO 2024 and for a fact-finding tour of Kyushu has wound up a hugely rewarding journey. Over the course of the two-day expo, the Kaohsiung Pavilion …

Read More »